ES368147A1 - Procedimiento para la preparacion de un compuesto farma- ceutico a base de antigenos bacterianos. - Google Patents
Procedimiento para la preparacion de un compuesto farma- ceutico a base de antigenos bacterianos.Info
- Publication number
- ES368147A1 ES368147A1 ES368147A ES368147A ES368147A1 ES 368147 A1 ES368147 A1 ES 368147A1 ES 368147 A ES368147 A ES 368147A ES 368147 A ES368147 A ES 368147A ES 368147 A1 ES368147 A1 ES 368147A1
- Authority
- ES
- Spain
- Prior art keywords
- bacteria
- bacterial antigens
- pneumonial
- lyophilized
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 abstract 3
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 210000002345 respiratory system Anatomy 0.000 abstract 2
- 239000004338 Dichlorodifluoromethane Substances 0.000 abstract 1
- 241000194032 Enterococcus faecalis Species 0.000 abstract 1
- 241000588748 Klebsiella Species 0.000 abstract 1
- 241000588653 Neisseria Species 0.000 abstract 1
- 241000588769 Proteus <enterobacteria> Species 0.000 abstract 1
- 241000588767 Proteus vulgaris Species 0.000 abstract 1
- 241000589516 Pseudomonas Species 0.000 abstract 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract 1
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 241000193996 Streptococcus pyogenes Species 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 abstract 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 229940007042 proteus vulgaris Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR155603A FR7461M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1968-06-19 | 1968-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES368147A1 true ES368147A1 (es) | 1971-05-01 |
Family
ID=8651343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES368147A Expired ES368147A1 (es) | 1968-06-19 | 1969-06-07 | Procedimiento para la preparacion de un compuesto farma- ceutico a base de antigenos bacterianos. |
Country Status (7)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1502774A (en) * | 1974-06-25 | 1978-03-01 | Nat Res Dev | Immunological preparations |
| DE2748132A1 (de) * | 1977-10-27 | 1979-05-03 | Behringwerke Ag | Stabilisator fuer polysaccharid |
| US4223014A (en) * | 1978-05-08 | 1980-09-16 | The United States Of America As Represented By The Secretary Of The Interior | Spray immunization of fish |
| CH633188A5 (fr) * | 1978-05-26 | 1982-11-30 | Om Laboratoires Sa | Medicament contre des maladies infectieuses des voies respiratoires. |
| US4225583A (en) * | 1978-12-07 | 1980-09-30 | Iowa State University Research Foundation, Inc. | Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use |
| JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
| CH664497A5 (de) * | 1984-08-31 | 1988-03-15 | Solco Basel Ag | Vakzine zur behandlung der harnwegsinfektionen. |
| US5766573A (en) * | 1988-12-06 | 1998-06-16 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| CA2097830C (en) * | 1990-12-04 | 2000-02-01 | Stephen G. Newman | Spray-dried antigenic products and method of preparation |
| EP0562125A4 (en) * | 1991-10-11 | 1994-03-18 | Toray Industries | Antibody composition. |
| US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
| US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
| US5552415A (en) * | 1993-12-21 | 1996-09-03 | Eli Lilly And Company | Method of inhibiting Alzheimer's Disease |
| US6290991B1 (en) | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| WO2003072016A2 (en) * | 2001-11-19 | 2003-09-04 | Becton, Dickinson And Company | Pharmaceutical compositions in particulate form |
| US20080170996A1 (en) * | 2006-07-28 | 2008-07-17 | The Board Of Regents Of The University Of Texas System | Compositions and Methods for Stimulation of Lung Innate Immunity |
| DE102007020578A1 (de) * | 2007-05-02 | 2008-11-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Wässrige Aerosolzubereitungen enthaltend therapeutisch wirksame Mikroorganismen oder Teile von Mikroorganismen und Verfahren zur Erzeugung entsprechender Aerosole |
| WO2010030790A2 (en) * | 2008-09-10 | 2010-03-18 | The Texas A&M University System | Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| ES2534947T3 (es) | 2009-03-25 | 2015-04-30 | The Board Of Regents Of The University Of Texas System | Composiciones para la estimulación de resistencia inmunitaria innata de mamíferos a patógenos |
| CN107096018A (zh) | 2009-05-27 | 2017-08-29 | 西莱克塔生物科技公司 | 具有免疫调节剂的pH敏感释放的靶向合成纳米载体 |
| AU2011258165B2 (en) | 2010-05-26 | 2016-11-17 | Selecta Biosciences, Inc. | Dose selection of adjuvanted synthetic nanocarriers |
| WO2013019658A2 (en) | 2011-07-29 | 2013-02-07 | Selecta Biosciences, Inc. | Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents |
| US10286065B2 (en) | 2014-09-19 | 2019-05-14 | Board Of Regents, The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
-
1968
- 1968-06-19 FR FR155603A patent/FR7461M/fr not_active Expired
-
1969
- 1969-06-07 ES ES368147A patent/ES368147A1/es not_active Expired
- 1969-06-16 US US833719A patent/US3608066A/en not_active Expired - Lifetime
- 1969-06-17 CA CA054602A patent/CA931074A/en not_active Expired
- 1969-06-18 BE BE734775D patent/BE734775A/xx not_active IP Right Cessation
- 1969-06-18 GB GB30844/69A patent/GB1243601A/en not_active Expired
- 1969-06-19 DE DE1931195A patent/DE1931195C3/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE1931195A1 (de) | 1970-01-29 |
| BE734775A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-12-18 |
| FR7461M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-01-05 |
| US3608066A (en) | 1971-09-21 |
| DE1931195B2 (de) | 1980-01-10 |
| GB1243601A (en) | 1971-08-25 |
| CA931074A (en) | 1973-07-31 |
| DE1931195C3 (de) | 1980-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES368147A1 (es) | Procedimiento para la preparacion de un compuesto farma- ceutico a base de antigenos bacterianos. | |
| Zak et al. | CGP 9000: A new orally active, broad-spectrum cephalosporin | |
| GEP19991538B (en) | Derivatives of Erytromycin and Pharmaceutical Composition on their Basis | |
| DE3277726D1 (en) | Use of alkaloid derivatives for the manufacture of a medicament for the strengthening of the immune system and for the treatment of viral, bacterial and fungal infections | |
| ES8700939A1 (es) | Un procedimiento para preparar una vacuna, compuesta en par-ticular sobre la base de escherichia coli | |
| SE8900546D0 (sv) | Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad | |
| MY104937A (en) | Cephalosporin derivatives and processes for their preparation | |
| DE3260277D1 (en) | Peptide antibiotic, component b, process for its preparation and its use in medicines | |
| FR2307542A1 (fr) | Nouvelle preparation immunostimulante | |
| ES8205809A1 (es) | Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas | |
| US3428730A (en) | Antibacterial mixture of o-carbamyl-d-serine and d-4-amino-3-isoxazolidone | |
| DE3260276D1 (en) | Peptide antibiotic, component a, process for its preparation and its use in medicines | |
| ES8104402A1 (es) | Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas. | |
| FR2463M (fr) | Médicament a base d'un dérivé de la 2.4-diaminopyrido[2.3-d]-pyrimidine, utilisable notamment contre les infections microbiennes. | |
| ES8702428A1 (es) | Un metodo para producir antibiotico tan-588 y-o n-desacetil-antibiotico tan-588 | |
| GB910456A (en) | Therapeutic compositions comprising a penicillin antibiotic and sulphonamides | |
| ES369356A1 (es) | Procedimiento de preparacion de sustancias polisacaridicas con propiedades antigenas y antibioticas minadoras. | |
| Usami et al. | Study of organisms isolated from non-infected patients with pneumoconiosis | |
| GB1252495A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Patterson | Effects of sub-minimal growth temperatures on the viability and injury of Staphylococcus aureus, Escherichia coli and Streptococcus faecalis | |
| OHNISHI et al. | Radio-sensitivities of microorganisms adhering to the crude drug" Glycyrrhizae Radix" | |
| ELALAENAERY et al. | Bacterial isolates from the respiratory tract of cattle and their zoonotic importance in Al-Qasseem, Saudi Arabia | |
| FR2162245A1 (en) | Micronized l-dopa - with increased bioavailability | |
| CA646287A (en) | 3-oxo-.delta.1,4 and .delta.1,4,6-steroids using 2,3-cyano-1,4-benzoquinones | |
| Ikeda et al. | Interactions of piperacillin or carbenicillin on the phagocytosis and killing of rabbit polymorphonuclear leukocytes. |